Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02265601
Other study ID # RSGHP-08-005-01-CPHPS
Secondary ID RSGHP-08-005-01-
Status Completed
Phase N/A
First received
Last updated
Start date March 2008
Est. completion date January 2017

Study information

Verified date December 2023
Source Milton S. Hershey Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is designed to help the investigators understand more about how people plan for their future medical needs, a process known as "advance care planning." The study is under the direction of Michael J. Green, M.D., and Benjamin Levi, M.D. physicians at Penn State Hershey Medical Center. Participation in the project takes place during a single visit to the Medical Center campus. During this one-to-three hour visit, participants complete several questionnaires and use a computer program that produces a printed advance directive that can be shared with their physicians and loved ones. Participants will receive compensation toward travel expenses.


Description:

Background: Despite widespread agreement that individuals ought to plan for their medical futures, few people (even seriously ill patients with cancer) actually complete advance directives, fewer yet understand key elements, and even when advance directives do exist, there are often barriers to their being implemented. Objectives: The investigators innovative, multimedia, interactive, computer-based decision aid, "Making Your Wishes Known: Planning Your Medical Future," offers tailored education, values clarification exercises, and a sophisticated decision aid that translates an individual's goals and preferences into a specific medical plan that can be implemented by a health care team. This project aims to evaluate its impact on decision-making and health care received by individuals at the end of life in a randomized clinical trial among a population of patients with advanced cancer who have life expectancies of < 12 months. Specific Aims: Aim 1: To evaluate the impact of a computer-based advance care planning intervention on end-of-life decision-making by cancer patients with estimated life expectancies < 12 months. The investigators hypothesize that, compared to standard care (paper/pencil living will form), use of the computer-based intervention will: H1: Improve individuals' decision-making about end-of-life health care H2: Improve individuals' experience with the process of advance care planning H3: Not increase individuals' hopelessness or anxiety, nor harm the doctor-patient relationship Aim 2: To evaluate the impact of the investigators intervention on end-of-life health care received by cancer patients with estimated life expectancies < 12 months. The investigators hypothesize that, compared to standard care, use of the computer intervention will: H4: Increase physician awareness of individuals' health care wishes H5: Increase physician adherence to individuals' health care wishes Study Design: Randomized, controlled pre-intervention/post-intervention trial comparing a computer-based educational intervention with standard care Cancer Relevance: Patients with advanced cancer face many medical decisions, some of which must be made when the patient cannot speak for him or herself. Helping these individuals to effectively articulate and communicate their wishes, in advance, can help assure that treatment they receive is consistent with their values, goals and wishes. This study aims to test the effectiveness of the investigators' computer-based intervention. If successful, this intervention can help improve the quality of health care received by cancer patients at the end of life.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date January 2017
Est. primary completion date January 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - 18 years of age or older - able to give informed consent - interested in participating in advance care planning - able to read and understand English at an 8th grade level (per WRAT-3 screening test) - advanced cancer (primary or metastatic), with estimated lifespan < 6 months (as determined by their treating physician) - cognitively able to engage in advance care planning (Mini Mental State Exam (MMSE) score >23) - absence of moderate or severe depression (BDI-II score <20/63) Exclusion Criteria: - unable to read and understand English at an 8th grade level (per Wide Range Achievement Test (WRAT-3)) - not cognitively able to engage in advance care planning (Mini Mental State Exam (MMSE) score < 23) - moderate or severe depression (BDI-II score >20/63)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
computer-based decision aid
Offers tailored education, values clarification exercises, and a sophisticated decision aid that translates an individual's goals and preferences into a specific medical plan that can be implemented by a health care team.
standard care
paper/pencil living will form

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Milton S. Hershey Medical Center American Cancer Society, Inc.

Outcome

Type Measure Description Time frame Safety issue
Primary Participant knowledge of advance care planning Knowledge of advance care planning will be compared between control and intervention groups, using a true/false and multiple choice questionnaire about advance care planning. Pre and post-intervention
Secondary Participant decisional conflict Assessment of conflict associated with making end-of-life decisions will be assessed with the decisional conflict scale. post-intervention
Secondary Participant satisfaction with decision Assessment of satisfaction with decisions associated with advance care planning will be assessed with the satisfaction with decision scale. post-intervention
Secondary Participant satisfaction with advance care planning Satisfaction with with advance care planning process will be compared between intervention and control group with a satisfaction questionnaire. post-intervention
Secondary Participant self-determination Self determination will be compared between intervention and control group with a self-determination questionnaire. pre and post-intervention
Secondary Participant anxiety Pre and post-intervention anxiety will be compared between intervention and control group with the state trait anxiety instrument. pre and post-intervention
Secondary Participant hopelessness Assessment of pre and post-intervention hopelessness will be compared between intervention and control group using the Beck Hopelessness scale and a measure of hopefulness. pre and post-intervention
Secondary Physician awareness of patients' health care wishes Comparison will be made between intervention and control group regarding whether an advance directive is present in the patient's medical record, and whether the physician is aware of the patient's wishes. post-death chart review
Secondary Physician adherence to patients' health care wishes Comparison will be made between intervention and control group regarding whether patients' wishes are followed at the end of life. post-death chart review
See also
  Status Clinical Trial Phase
Completed NCT03826043 - THrombo-Embolic Event in Onco-hematology N/A
Terminated NCT03166631 - A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread Phase 1
Completed NCT01938846 - BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors Phase 1
Recruiting NCT06058312 - Individual Food Preferences for the Mediterranean Diet in Cancer Patients N/A
Completed NCT03308942 - Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants Phase 2
Recruiting NCT06018311 - Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads N/A
Withdrawn NCT05431439 - Omics of Cancer: OncoGenomics
Completed NCT01343043 - A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma Phase 1
Completed NCT01938638 - Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer Phase 1
Recruiting NCT05514444 - Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001) Phase 1
Recruiting NCT02292641 - Beyond TME Origins N/A
Terminated NCT00954512 - Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004) Phase 1/Phase 2
Recruiting NCT04958239 - A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) Phase 1
Recruiting NCT04627376 - Multimodal Program for Cancer Related Cachexia Prevention N/A
Completed NCT01222728 - Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
Recruiting NCT06004440 - Real World Registry for Use of the Ion Endoluminal System
Active, not recruiting NCT05636696 - COMPANION: A Couple Intervention Targeting Cancer-related Fatigue N/A
Not yet recruiting NCT06035549 - Resilience in East Asian Immigrants for Advance Care Planning Discussions N/A
Recruiting NCT06004466 - Noninvasive Internal Jugular Venous Oximetry
Completed NCT02909348 - Immunophenotyping of Melanoma Patients on Treatment With Pembrolizumab